Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chackalamannil

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetesYan Xia, Samuel Chackalamannil, William J Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ringYan Xia, Samuel Chackalamannil, Tze-Ming Chan, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activitySamuel Chackalamannil, Yuguang Wang, William J Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2012
Discovery of nor-seco himbacine analogs as thrombin receptor antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2008
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonistsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ringYan Xia, Samuel Chackalamannil, Martin Clasby, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.
Journal of Medicinal Chemistry|September 16, 2005
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia, William J Greenlee, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 DiabetesSanthosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, et al.
Journal of Medicinal Chemistry|September 15, 2007
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 4, 2011
Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetesYan Xia, Samuel Chackalamannil, William J Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ringYan Xia, Samuel Chackalamannil, Tze-Ming Chan, et al.
Journal of Medicinal Chemistry|May 2, 2008
Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activitySamuel Chackalamannil, Yuguang Wang, William J Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2012
Discovery of nor-seco himbacine analogs as thrombin receptor antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2008
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonistsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ringYan Xia, Samuel Chackalamannil, Martin Clasby, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.
Journal of Medicinal Chemistry|September 16, 2005
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agentsSamuel Chackalamannil, Yan Xia, William J Greenlee, et al.
ACS Medicinal Chemistry Letters|May 26, 2018
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 DiabetesSanthosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, et al.
Journal of Medicinal Chemistry|September 15, 2007
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonistsMariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Pageof 5